Vascular & Endovascular Highlights: Blood thinner recalled due to cancer risk | Intravascular imaging-guided PCI

The recall, announced by the FDA, includes multiple lots of dabigatran etexilate capsules.

Eric Secemsky, MD, told Cardiovascular Business that a lack of training is one of the biggest factors limiting the use of intravascular imaging-guided PCI among interventional cardiologists. 

The study’s primary endpoint, amputation-free survival after six months, was seen in 66.1% of CLTI patients who underwent transcatheter arterialization.

After its initial release was limited to certain customers, the new-look catheter is now available in four different sizes throughout the United States.

Using the World Health Organization’s model for analyzing gender-related healthcare needs, the authors of a new analysis aimed to explore disparities in PAD outcomes.